PET in breast cancer

Seminars in Nuclear Medicine

Volumn 28, Issue 4, 1998, Pages 290-302

  Flanagan, F L ^a   Dehdashti, F ^a   Siegel, B A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; FLUORODEOXYGLUCOSE F 18;

BREAST CANCER; CANCER LOCALIZATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RADIOISOTOPE DISTRIBUTION; REVIEW;

EID: 0031722831     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-2998(98)80034-2     Document Type: Article

References (58)

1. Landis SH Taylor M Bolden S Cancer statistics 1998 CA Cancer J Clin 48 1992 6 29
2. Rigo P Paulus P Kaschten BJ Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose Eur J Nucl Med 23 1996 1641 1674
3. Warburg O The metabolism of tumors 1930 Arnold Constable London 75 327
4. Monakhov NK Neisfadt EL Shavlovskii MM Physiochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues J Natl Cancer Inst 61 1978 27 34
5. Weber MJ Nakamura KD Salter DW Molecular events leading to enhanced glucose transport in Rous sarcoma virus-transformed cells Federation Proc 43 1984 2246 2250
6. Brown RS Wahl RL Over expression of Glut-1 glucose transporter in human breast cancer: an immunohistochemical study Cancer 72 1993 2979 2985
7. Xu M Luk WK Cutler PD Local threshold for segmented attenuation correction of PET imaging of the thorax IEEE Trans Nucl Sci 41 1994 1532 1537
8. Kubota K Matsuzawa T Ito M Lung tumor imaging by positron emission tomography using C-11 L-methionine J Nucl Med 26 1985 37 42
9. Zasadny K Wahl RL Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction Radiology 189 1993 847 850
10. Avril N Bense S Ziegler SI Breast imaging with fluorine-18-FDG PET: quantitative image analysis J Nucl Med 38 1997 1186 1191
11. Avril N Dose F Bense S Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose J Clin Oncol 14 1996 1848 1857
12. Wahl RL Henry CA Ethier SP Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma Radiology 183 1992 643 647
13. Patlak CS Blasberg RG Graphical evaluation of blood-to-brain transfer constant from multiple-time uptake data. Generalization J Cereb Blood Flow Metab 5 1985 584 590
14. Wahl RL Zasadny K Helvie M Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation J Clin Oncol 11 1993 2101 2111
15. Tabar L Faggerberg G Chen HH Efficacy of breast cancer screening by age. New results from Swedish two-country trial Cancer 75 1995 2507 2514
16. Tse NY Hoh K Hawkins RA The application of positron emission tomography with fluorodeoxyglucose to the evaluation of breast disease Ann Surg 216 1992 27 34
17. Wahl RL Cody RL Hutchins GD Primary and metastatic breast carcinoma: initial clinical evaluation with PEt with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose Radiology 179 1991 765 770
18. Nieweg OE Kim EE Wong WH Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer Cancer 71 1993 3920 3925
19. 18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability Eur J Nucl Med 23 1996 618 623
20. Adler LP Crowe JP Al-Kaisi NK Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET Radiology 187 1993 743 750
21. 18F]fluoro-2-deoxy-D-glucose J Comput Assist Tomogr 17 1993 582 589
22. Kubota R Yamada S Kubota K Intratumoral distribution of fluorine-18-deoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiographic comparison with FDG J Nucl Med 33 1992 1972 1980
23. Wahl RL Helvie MA Chang AE Detection of breast cancer in women after augmentation mammoplasty using fluorine-18-deoxyglucose-PET J Nucl Med 35 1994 872 875
24. Harris JR Morrow M Bonadonna G Cancer of the breast Devita VT Jr Hellman S Rosenberg SA Cancer: principles and practice of oncology 4th Ed 1993 Lippincott Philadelphia, PA 1264 1332
25. 18FDG uptake in human tumor xenografts: feasibility studies for cancer imaging Cancer 67 1991 1544 1550
26. Adler LP Cascade E Crowe J Axillary lymph node involvement in breast cancer: a retrospective study Presented at 1994 ICP Meeting San Francisco, CA Oct. 25–29, 1994
27. Avril N Dose J Jäniicke F Assessment of axillary lymph node involvement in breast patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D glucose J Natl Cancer Inst 88 1996 1204 1209
28. Utech CI Young CS Winter PF Prospective evaluation of fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry Eur J Nucl Med 23 1996 1588 1593
29. Adler DD Wahl RL New methods for imaging the breast: techniques, findings, and potential AJR 164 1995 19 30
30. Haberkorn U Reinhardt M Strauss LG Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy J Nucl Med 33 1992 1981 1987
31. 18F]fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer Eur J Nucl Med 15 1989 61 66
32. Jansson T Westlin JE Ahlström H Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation J Clin Oncol 13 1995 1470 1477
33. Nieweg OE Wong W-H Singletary SE Positron emission tomography of glucose metabolism in breast cancer. Potential for tumor detection, staging, and evaluation of chemotherapy Ann N Y Acad Sci 689 1993 423 428
34. Bassa P Kim EE Inoue T Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer J Nucl Med 37 1996 931 938
35. Vollenweider-Zerargui L Barrelet L Wong Y The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women: clinical correlation on 547 patients Cancer 57 1986 1171 1180
36. Ravdin PM Green S Dorr TM Prognostic significance of progesterone receptor levels in estrogen receptorpositive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study J Clin Oncol 10 1992 1284 1291
37. Katzenellenbogen JA Designing steroid receptor-based radiotracers to image breast and prostate tumors J Nucl Med 36 Suppl 1995 8 13
38. Kiesewetter DO Kilbourn MR Landvatter SW Radiochemistry and radiopharmaceuticals J Nucl Med 25 1984 1212 1221
39. 18F] fluoro-17β-estradiol in DMBA-induced mammary tumors Int J Rad Appl Instrum [B] 14 1987 15 25
40. Brodack JW Kilbourn MR Welch MJ Application of robotics to radiopharmaceutical preparation: controlled synthesis of fluorine-18 16α-fluoroestradiol-17β J Nucl Med 27 1986 714 721
41. 18F]fluoroestradiol-17β: the effect of reaction vessel on fluorine-18 resolubilization, product yield and effective specific activity Int J Radiat Appl Instrum [A] 37 1986 217 221
42. Mintun MA Welch MJ Siegel BA Breast cancer: PET imaging of estrogen receptors Radiology 169 1988 45 48
43. 18F]fluoro-17β-estradiol uptake in metastatic breast carcinoma J Nucl Med 32 1991 1526 1531
44. Dehdashti F Mortimer JE Siegel BA Positron tomographic assessment of estrogen receptors in breast cancer. Comparison with FDG-PET and in vitro receptor assays J Nucl Med 36 1995 1766 1774
45. Mortimer JE Dehdashti F Siegel BA Clinical correlation of FDG and FES-PET imaging with estrogen receptor and response to systemic therapy Clin Cancer Res 2 1996 933 939
46. Butler JA Trezona T Vargas H Value of measuring hormone receptor levels of regional metastatic carcinoma of the breast Arch Surg 124 1989 1131 1136
47. Campbell FC Blamey RW Elston CW Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy Lancet 2 1981 1317 1319
48. 18F]fluoro-16α-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas J Nucl Med 32 1991 1532 1537
49. Katzenellenbogen JA Welch MJ Dehdashti F The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer Anticancer Res 17 1997 1573 1576
50. 18F]fluoro-16α-ethyl-19-norprogesterone) in humans: a clue for future investigations Nucl Med Biol 21 1994 941 952
51. 18F]fluorotamoxifen for imaging breast tumors J Drug Target 1 1993 259 267
52. Yang DJ Li C Kaung L-R Imaging, biodistribution and therapy potential of halogenated tamoxifen analogues Life Sci 55 1994 53 67
53. Plotkin D Lechner JJ Jung WE Tamoxifen flare in advanced breast cancer JAMA 240 1978 2644 2646
54. Legha SS Tamoxifen in the treatment of breast cancer Ann Intern Med 109 1988 219 228
55. Vogel CL Schoenfelder J Shemano I Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer J Clin Oncol 13 1995 1123 1128
56. Welch MJ Bonasera TA Sherman EIC [F-18]fluorodeoxyglucose (FDG) and 16α[F-18]fluoroestradiol-17β (FES) uptake in estrogen-receptor (ER)-rich tissues following tamoxifen treatment: a preclinical study J Nucl Med 36 1995 39
57. Wahl RL Cody R Fisher S FDG uptake before and after estrogen receptor stimulation: feasibility studdies for functional receptor imaging J Nucl Med 32 1991 1011
58. Dehdashti F Flanagan FL Siegel BA PET assessment of metabolic flare in advanced brest cancer Radiology 205 1997 220